Lista de obras -

18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors

artículo científico publicado en 2013

A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index

scientific article published on 09 December 2019

A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia.

artículo científico publicado en 2016

A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors.

artículo científico publicado en 2012

A phase I pharmacologic and pharmacogenetic trial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult patients with solid tumors.

artículo científico publicado en 2005

A phase I study of myo-inositol for lung cancer chemoprevention

artículo científico publicado en 2006

A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia

artículo científico publicado en 2013

A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer

scientific article published on 01 June 2019

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.

artículo científico publicado en 2013

A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study.

artículo científico publicado en 2014

A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum

artículo científico publicado en 2015

A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol

scientific article published on 01 April 2019

A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium.

artículo científico publicado en 2004

A web-based screening and accrual strategy for a cancer prevention clinical trial in healthy smokers

artículo científico publicado en 2012

AACR Cancer Progress Report 2015

artículo científico publicado en 2015

AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health

scientific article published on 01 December 2018

Acceptability of Localized Cancer Risk Reduction Interventions Among Individuals at Average or High Risk for Cancer

scientific article published on 01 March 2019

Airway brushing as a new experimental methodology to detect airway gene expression signatures in mouse lung squamous cell carcinoma.

artículo científico publicado en 2018

Alterations in differentiation and apoptosis induced by bufalin in cJun overexpressing U-937 cells ⬇️

artículo científico publicado el 1 de febrero de 1998

Altered Histology Provides a Positive Clinical Signal in the Bronchial Epithelium ⬇️

artículo científico publicado el 1 de junio de 2011

Altered cJUN expression: an early event in human lung carcinogenesis

artículo científico publicado en 1996

Assessing efficacy in early-phase cancer prevention trials: the case of oral premalignancy

scientific article published on 01 October 2008

Assessment of and interventions for women at high risk for breast or ovarian cancer: A survey of primary care physicians

scientific article published on 06 October 2020

Biomarkers in phase I-II chemoprevention trials: lessons from the NCI experience

artículo científico publicado en 2015

Bronchial airway gene expression signatures in mouse lung squamous cell carcinoma and their modulation by cancer chemopreventive agents.

scientific article published on 07 December 2016

Cancer Prevention in Primary Care: Perception of Importance, Recognition of Risk Factors and Prescribing Behaviors

artículo científico publicado en 2019

Cancer and inflammation: promise for biologic therapy.

artículo científico publicado en 2010

Cancer prevention in the era of precision oncology

artículo científico publicado en 2016

Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening

scientific article published on 03 August 2018

Characterization and management of cardiac involvement of thymic epithelial tumors

artículo científico publicado en 2013

Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

artículo científico publicado en 2013

Chemoprevention of lung cancer: new directions.

artículo científico publicado en 2003

Chemoprevention of lung carcinogenesis by the combination of aerosolized budesonide and oral pioglitazone in A/J mice.

artículo científico publicado en 2011

Chemopreventive effect of a mixture of Chinese Herbs (antitumor B) on chemically induced oral carcinogenesis.

artículo científico publicado en 2011

Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial

artículo científico publicado en 2014

Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical research

artículo científico publicado en 2016

Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations.

artículo científico publicado en 2013

Consolidative local therapy in oligometastatic patients

artículo científico publicado en 2017

Correlation analysis of oral lesion sizes by various standardized criteria

artículo científico publicado en 2016

Criteria of evidence to move potential chemopreventive agents into late phase clinical trials.

artículo científico publicado en 2011

Dermatomyositis paraneoplastic syndrome before symptomatic tonsillar squamous cell carcinoma: a case report

artículo científico publicado en 2014

Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study

scientific article published on 04 May 2019

Early detection of lung cancer

scientific article published on 01 August 1993

Early events in the neoplastic transformation of respiratory epithelium

artículo científico publicado el 1 de enero de 1992

Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).

artículo científico publicado en 1996

Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer

artículo científico publicado en 2017

Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes.

artículo científico publicado en 2008

Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung.

artículo científico publicado en 2002

Fifty years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancer

artículo científico publicado en 2014

Hepatoid adenocarcinoma of the lung metastasizing to the tonsil.

artículo científico publicado en 2017

How should we move the field of chemopreventive agent development forward in a productive manner?

artículo científico publicado en 2005

Images in clinical medicine. Sunitinib-associated hair depigmentation

artículo científico publicado en 2014

Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods

scientific article published on 01 February 1989

Implications of the "Bad Luck" Explanation of Cancer Risk for the Field of Cancer Prevention

artículo científico publicado en 2015

Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer

artículo científico publicado en 2000

Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial

scientific article published on 12 November 2018

Intermediate Markers and Molecular Genetics of Lung Carcinogenesis.

artículo científico publicado en 1997

Long-term effects of inhaled budesonide on screening-detected lung nodules.

artículo científico publicado en 2015

Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research

artículo científico publicado en 2009

Lung cancer screening: a different paradigm.

artículo científico publicado en 2003

Lung epithelial proliferation: a biomarker for chemoprevention trials?

scientific article published on 01 July 2001

MUC1 expression in lung cancer

artículo científico publicado en 2003

Major conceptual change required to improve lung cancer: see a respiratory physician.

artículo científico publicado en 2003

Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders

artículo científico publicado en 2014

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial

artículo científico publicado en 2015

Novel mutational landscapes and expression signatures of lung squamous cell carcinoma

artículo científico publicado en 2017

Overexpression of CC10 modifies neoplastic potential in lung cancer cells.

artículo científico publicado en 1998

PPARγ in head and neck cancer prevention

artículo científico publicado en 2014

Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule.

artículo científico publicado en 2003

Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668 ⬇️

artículo científico publicado el 1 de marzo de 2011

Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors.

artículo científico publicado en 2005

Phase II cancer prevention clinical trials

artículo científico publicado en 2010

Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors

artículo científico publicado en 2011

Pioglitazone-mediated reversal of elevated glucose metabolism in the airway epithelium of mouse lung adenocarcinomas

artículo científico publicado en 2017

Population Pharmacokinetic Model for Cancer Chemoprevention With Sulindac in Healthy Subjects ⬇️

artículo científico publicado el 22 de febrero de 2013

Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung Cancer

scientific article published on 15 April 2019

Preinvasive Endobronchial Lesions: Lung Cancer Precursors and Risk Markers?

artículo científico publicado en 2015

Primer: first do no harm--when is it appropriate to plan a cancer prevention clinical trial?

scientific article published on 29 April 2008

Proliferative changes in chemoprevention trials: learning from secondary endpoints.

artículo científico publicado en 2007

Randomized controlled trials of the efficacy of lung cancer screening by sputum cytology revisited: a combined mortality analysis from the Johns Hopkins Lung Project and the Memorial Sloan-Kettering Lung Study.

artículo científico publicado en 2009

Randomized phase II trial of inhaled budesonide versus placebo in high-risk individuals with CT screen-detected lung nodules

artículo científico publicado en 2010

Randomized phase II trial of sulindac for lung cancer chemoprevention.

artículo científico publicado en 2012

Reduced IL-6 levels and tumor-associated phospho-STAT3 are associated with reduced tumor development in a mouse model of lung cancer chemoprevention with myo-inositol

artículo científico publicado en 2017

Regulatory approval of cancer risk-reducing (chemopreventive) drugs: moving what we have learned into the clinic

artículo científico publicado en 2011

Repurposing Drugs for Cancer Prevention.

artículo científico publicado en 2016

Repurposing old drugs to chemoprevention: the case of metformin.

artículo científico publicado en 2015

Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.

artículo científico publicado en 1996

Role of c-jun in human myeloid leukemia cell apoptosis induced by pharmacological inhibitors of protein kinase C.

artículo científico publicado en 1996

Selumetinib with and without erlotinib in KRAS mutant and KRAS wild-type advanced nonsmall-cell lung cancer.

artículo científico publicado en 2016

Short- and long-term lung cancer risk associated with noncalcified nodules observed on low-dose CT

artículo científico publicado en 2014

Sunitinib in patients with chemotherapy-refractory thymoma and thymic carcinoma: an open-label phase 2 trial.

artículo científico publicado en 2015

Sustained response of carcinoma ex pleomorphic adenoma treated with trastuzumab and capecitabine.

artículo científico publicado en 2010

The Ninth Annual American Association of cancer research international conference on frontiers in cancer prevention research.

artículo científico publicado en 2011

The association between the anti-inflammatory protein CC10 and smoking status among participants in a chemoprevention trial

artículo científico publicado en 2007

The role of jun and fos gene family members in 12-O-tetradecanoylphorbol-13-acetate induced hemopoietic differentiation ⬇️

artículo científico publicado el 1 de octubre de 1991

Transforming Cancer Prevention through Precision Medicine and Immune-oncology.

artículo científico publicado en 2016

Use of markers for the detection and treatment of lung cancer

artículo científico publicado en 2004

Validation of LOH profiles for assessing oral cancer risk.

artículo científico publicado en 2012

Workshop on imaging science development for cancer prevention and preemption.

artículo científico publicado en 2007

Lista de obras de

18F-fluorodeoxyglucose positron emission tomography in the management of patients with thymic epithelial tumors

A Phase IIa Trial of Metformin for Colorectal Cancer Risk Reduction among Individuals with History of Colorectal Adenomas and Elevated Body Mass Index

A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia.

A phase I combination study of olaparib with cisplatin and gemcitabine in adults with solid tumors.

A phase I pharmacologic and pharmacogenetic trial of sequential 24-hour infusion of irinotecan followed by leucovorin and a 48-hour infusion of fluorouracil in adult patients with solid tumors.

A phase I study of myo-inositol for lung cancer chemoprevention

A phase I trial of aminolevulinic acid-photodynamic therapy for treatment of oral leukoplakia

A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer

A phase I/II study of sepantronium bromide (YM155, survivin suppressor) with paclitaxel and carboplatin in patients with advanced non-small-cell lung cancer.

A phase I/II trial of belinostat in combination with cisplatin, doxorubicin, and cyclophosphamide in thymic epithelial tumors: a clinical and translational study.

A phase IIa randomized, double-blind trial of erlotinib in inhibiting epidermal growth factor receptor signaling in aberrant crypt foci of the colorectum

A prospective, single-arm, open-label, non-randomized, phase IIa trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys - clinical protocol

A randomized phase IIb trial of pulmicort turbuhaler (budesonide) in people with dysplasia of the bronchial epithelium.

A web-based screening and accrual strategy for a cancer prevention clinical trial in healthy smokers

AACR Cancer Progress Report 2015

AACR White Paper: Shaping the Future of Cancer Prevention - A Roadmap for Advancing Science and Public Health

Acceptability of Localized Cancer Risk Reduction Interventions Among Individuals at Average or High Risk for Cancer

Airway brushing as a new experimental methodology to detect airway gene expression signatures in mouse lung squamous cell carcinoma.

Alterations in differentiation and apoptosis induced by bufalin in cJun overexpressing U-937 cells ⬇️

Altered Histology Provides a Positive Clinical Signal in the Bronchial Epithelium ⬇️

Altered cJUN expression: an early event in human lung carcinogenesis

Assessing efficacy in early-phase cancer prevention trials: the case of oral premalignancy

Assessment of and interventions for women at high risk for breast or ovarian cancer: A survey of primary care physicians

Biomarkers in phase I-II chemoprevention trials: lessons from the NCI experience

Bronchial airway gene expression signatures in mouse lung squamous cell carcinoma and their modulation by cancer chemopreventive agents.

Cancer Prevention in Primary Care: Perception of Importance, Recognition of Risk Factors and Prescribing Behaviors

Cancer and inflammation: promise for biologic therapy.

Cancer prevention in the era of precision oncology

Characteristics and Outcomes of Small Cell Lung Cancer Detected by CT Screening

Characterization and management of cardiac involvement of thymic epithelial tumors

Chemoprevention of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines

Chemoprevention of lung cancer: new directions.

Chemoprevention of lung carcinogenesis by the combination of aerosolized budesonide and oral pioglitazone in A/J mice.

Chemopreventive effect of a mixture of Chinese Herbs (antitumor B) on chemically induced oral carcinogenesis.

Cixutumumab for patients with recurrent or refractory advanced thymic epithelial tumours: a multicentre, open-label, phase 2 trial

Cognitive testing of tobacco use items for administration to patients with cancer and cancer survivors in clinical research

Concurrent molecular alterations in tumors with germ line epidermal growth factor receptor T790M mutations.

Consolidative local therapy in oligometastatic patients

Correlation analysis of oral lesion sizes by various standardized criteria

Criteria of evidence to move potential chemopreventive agents into late phase clinical trials.

Dermatomyositis paraneoplastic syndrome before symptomatic tonsillar squamous cell carcinoma: a case report

Durvalumab in Combination with Olaparib in Patients with Relapsed SCLC: Results from a Phase II Study

Early detection of lung cancer

Early events in the neoplastic transformation of respiratory epithelium

Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67).

Effect of weekly or daily dosing regimen of Gefitinib in mouse models of lung cancer

Effects of gefitinib (Iressa) on mammary cancers: preventive studies with varied dosages, combinations with vorozole or targretin, and biomarker changes.

Enhanced growth inhibition by combination differentiation therapy with ligands of peroxisome proliferator-activated receptor-gamma and inhibitors of histone deacetylase in adenocarcinoma of the lung.

Fifty years of tobacco carcinogenesis research: from mechanisms to early detection and prevention of lung cancer

Hepatoid adenocarcinoma of the lung metastasizing to the tonsil.

How should we move the field of chemopreventive agent development forward in a productive manner?

Images in clinical medicine. Sunitinib-associated hair depigmentation

Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods

Implications of the "Bad Luck" Explanation of Cancer Risk for the Field of Cancer Prevention

Induction of differentiation and apoptosis by ligands of peroxisome proliferator-activated receptor gamma in non-small cell lung cancer

Inhibition of mTOR Signaling and Clinical Activity of Rapamycin in Head and Neck Cancer in a Window of Opportunity Trial

Intermediate Markers and Molecular Genetics of Lung Carcinogenesis.

Long-term effects of inhaled budesonide on screening-detected lung nodules.

Lung cancer and chronic obstructive pulmonary disease: needs and opportunities for integrated research

Lung cancer screening: a different paradigm.

Lung epithelial proliferation: a biomarker for chemoprevention trials?

MUC1 expression in lung cancer

Major conceptual change required to improve lung cancer: see a respiratory physician.

Metformin and cancer risk and mortality: a systematic review and meta-analysis taking into account biases and confounders

Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial

Novel mutational landscapes and expression signatures of lung squamous cell carcinoma

Overexpression of CC10 modifies neoplastic potential in lung cancer cells.

PPARγ in head and neck cancer prevention

Pharmacokinetic and pharmacodynamic effects of oral eniluracil, fluorouracil and leucovorin given on a weekly schedule.

Phase 0 Clinical Chemoprevention Trial of the Akt Inhibitor SR13668 ⬇️

Phase I and pharmacologic study of 17-(allylamino)-17-demethoxygeldanamycin in adult patients with solid tumors.

Phase II cancer prevention clinical trials

Phase II study of belinostat in patients with recurrent or refractory advanced thymic epithelial tumors

Pioglitazone-mediated reversal of elevated glucose metabolism in the airway epithelium of mouse lung adenocarcinomas

Population Pharmacokinetic Model for Cancer Chemoprevention With Sulindac in Healthy Subjects ⬇️

Potential Influence on Clinical Trials of Long-Term Survivors of Stage IV Non-small cell Lung Cancer

Preinvasive Endobronchial Lesions: Lung Cancer Precursors and Risk Markers?

Primer: first do no harm--when is it appropriate to plan a cancer prevention clinical trial?

Proliferative changes in chemoprevention trials: learning from secondary endpoints.